Comparative genomic analysis of two emergent human adenovirus type 14 respiratory pathogen isolates in China reveals similar yet divergent genomes.
Comparative genomic analysis of two emergent human adenovirus type 14 respiratory pathogen isolates in China reveals similar yet divergent genomes.
复制标题
中国两种新出现的人类腺病毒 14 型呼吸道病原体分离株的比较基因组分析揭示了相似但不同的基因组
DOI:
10.1038/emi.2017.78
复制
发表时间:
2017-11-01
影响因子:
13.2
通讯作者:
Seto D
中科院分区:
文献类型:
--
作者:
Zhang Q;Jing S;Cheng Z;Yu Z;Dehghan S;Shamsaddini A;Yan Y;Li M;Seto D
Human adenovirus type 14 (HAdV-B14p) was originally identified as an acute respiratory disease (ARD) pathogen in The Netherlands in 1955. For approximately fifty years, few sporadic infections were observed. In 2005, HAdV-B14p1, a genomic variant, re-emerged and was associated with several large ARD outbreaks across the U.S. and, subsequently, in Canada, the U.K., Ireland, and China. This strain was associated with an unusually higher fatality rate than previously reported for both this prototype and other HAdV types in general. In China, HAdV-B14 was first observed in 2010, when two unrelated HAdV-B14-associated ARD cases were reported in Southern China (GZ01) and Northern China (BJ430), followed by three subsequent outbreaks. While comparative genomic analysis, including indel analysis, shows that the three China isolates, with whole genome data available, are similar to the de Wit prototype, all are divergent from the U.S. strain (303600; 2007). Although the genomes of strains GZ01 and BJ430 are nearly identical, as per their genome type characterization and percent identities, they are subtly divergent in their genome mutation patterns. These genomes indicate possibly two lineages of HAdV-B14 and independent introductions into China from abroad, or subsequent divergence from one; CHN2012 likely represents a separate sub-lineage. Observations of these simultaneously reported emergent strains in China add to the understanding of the circulation, epidemiology, and evolution of these HAdV pathogens, as well as provide a foundation for developing effective vaccines and public health strategies, including nationwide surveillance in anticipation of larger outbreaks with potentially higher fatality rates associated with HAdV-B14p1.Emerging Microbes & Infections(2017)6,e92; doi:10.1038/emi.2017.78; published online 1 November 2017
登录
查看更多内容
影响因子:
3.7
作者:
Dehghan, Shoaleh;Seto, Jason;Jones, Morris S.;Dyer, David W.;Chodosh, James;Seto, Donald
通讯作者:
Seto, Donald
影响因子:
3.8
作者:
Hage, Elias;Liebert, Uwe Gerd;Heim, Albert
通讯作者:
Heim, Albert
影响因子:
6.4
作者:
Lewis, Paul F.;Schmidt, Mark A.;Gilbert, David
通讯作者:
Gilbert, David
影响因子:
9.4
作者:
De Jong, JC;Wermenbol, AG;Hierholzer, JC
通讯作者:
Hierholzer, JC
影响因子:
--
作者:
KENDALL, EJC;RIDDLE, RW;MCDONALD, JC
通讯作者:
MCDONALD, JC